STOCK TITAN

HYSTER-YALE, INC. (HY) SEC Filings, Aug-Oct 2025

HY NYSE

Welcome to our dedicated page for HYSTER-YALE SEC filings (Ticker: HY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on HYSTER-YALE's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into HYSTER-YALE's regulatory disclosures and financial reporting.

Rhea-AI Summary

Claiborne R. Rankin, a director of Hyster-Yale, Inc. (HY), reported an acquisition of 963 shares of Class A common stock on 10/01/2025 as "Required Shares" under the companys Non-Employee Directors Equity Compensation Plan. After the reported transaction, the filing shows 243,245 shares of Class A common stock beneficially owned by the reporting person, largely held indirectly through trusts, limited partnerships and interests attributed to the reporting persons spouse. The Form 4 discloses multiple indirect holdings and trustee roles rather than open-market purchases or sales, and the reporting person disclaims beneficial ownership for certain trust-held shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Reporting person: Poor Vincent, listed as a director of HYSTER-YALE, INC. (HY). On 10/01/2025 Mr. Vincent was awarded 963 shares of Class A Common Stock as "Required Shares" under the company's Non-Employee Directors' Equity Compensation Plan at a reported price of $0. After the award he beneficially owned 20,451 shares, held directly. The Form 4 was signed by an attorney-in-fact, Suzanne S. Taylor, on 10/02/2025.

This filing documents a routine equity award to a director recorded as a non-derivative acquisition; it shows the change in direct beneficial ownership and identifies the award as compensation-related under the director equity plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

The reporting person, John P. Jumper, a director of Hyster-Yale, received 963 shares of Class A common stock as award "Required Shares" under the companys Non-Employee Directors' Equity Compensation Plan. Following the transaction the reporting person beneficially owns 26,837 shares of Class A common stock. The Form 4 indicates this was a non-derivative acquisition recorded with transaction code A and a $0 price, consistent with stock awards issued as compensation to a director.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Carolyn Corvi, a director of HYSTER-YALE, INC. (HY), reported an acquisition of 963 shares of Class A common stock on 10/01/2025. The reported transaction code is A (acquisition) at a reported price of $0.00, leaving her with 26,185 shares beneficially owned following the transaction. The Form 4 was signed by an attorney-in-fact on 10/02/2025. The filing is a single-person Form 4 and lists the reporting person as a director.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Gary Collar L, a director of HYSTER-YALE, INC. (HY), received equity awards on 10/01/2025 under the company's Non-Employee Directors' Equity Compensation Plan. The filing shows two grant entries: 963 shares issued as "Required Shares" and 648 shares issued as "Voluntary Shares," both with a $0 price, indicating they were awarded rather than purchased. After the transactions the reporting person is shown as directly owning 6,729 shares of Class A common stock. The Form 4 was signed by an attorney-in-fact on 10/02/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

John C. Butler Jr., a director of Hyster-Yale, Inc. (HY), reported an acquisition of Class A common stock on 10/01/2025. The Form 4 shows an award of 963 Class A shares to the reporting person at a $0 price described as "Required Shares" under the company's Non-Employee Directors' Equity Compensation Plan. The filing lists a variety of indirect holdings held in trusts, partnerships, and an IRA, including 56,985 shares held in a trust for the reporting person and additional indirect interests across family trusts and partnerships. The filing was signed by an attorney-in-fact on 10/02/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

James Bemowski, a director of HYSTER-YALE, INC. (HY), was awarded 963 shares of Class A Common Stock on 10/01/2025 as required equity compensation for non-employee directors. Following this award, Bemowski beneficially owns 18,683 shares of Class A Common Stock. The transaction is reported as an acquisition at a $0 price because these were award shares issued under the company Non-Employee Directors' Equity Compensation Plan.

The Form 4 filing was executed on 10/02/2025 by Suzanne S. Taylor as attorney-in-fact. The report is a single-person filing and identifies Bemowski as a director. No derivative transactions, cash payments, or changes to previously reported holdings are disclosed in this form.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

HYSTER-YALE director Colleen Batcheler reported acquiring 963 Class A Common Stock shares on 10/01/2025 at $0 per share as "Required Shares" under the company's Non-Employee Directors' Equity Compensation Plan. After the award, the reporting person beneficially owns 6,816 shares indirectly, held in trust. The Form 4 was filed by a single reporting person and signed by an attorney-in-fact on 10/02/2025. The disclosure indicates a routine equity grant to a director rather than a market purchase or sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

John P. Jumper, a director of Hyster-Yale, Inc. (HY), reported a transaction dated 09/09/2025 exchanging 326 Class B shares for 326 Class A shares under transaction code J(1). After the exchange he beneficially owns 25,874 shares of Class A common stock and no derivative securities. The Form 4 was signed by an attorney-in-fact on 09/11/2025 and states the exchange converted the reporting person’s Class B shares into Class A shares; no cash consideration was reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.37%
Tags
current report

FAQ

How many HYSTER-YALE (HY) SEC filings are available on StockTitan?

StockTitan tracks 150 SEC filings for HYSTER-YALE (HY), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for HYSTER-YALE (HY)?

The most recent SEC filing for HYSTER-YALE (HY) was filed on October 2, 2025.